IMVT
Price
$38.62
Change
-$0.86 (-2.18%)
Updated
Jul 31 closing price
Capitalization
7.93B
3 days until earnings call
Intraday BUY SELL Signals
NAMS
Price
$27.79
Change
-$0.67 (-2.35%)
Updated
Jul 31 closing price
Capitalization
3.25B
9 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs NAMS

IMVT vs NAMS Comparison Chart in %
View a ticker or compare two or three
VS
IMVT vs. NAMS commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and NAMS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (IMVT: $38.62 vs. NAMS: $27.79)
Brand notoriety: IMVT and NAMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 29% vs. NAMS: 63%
Market capitalization -- IMVT: $7.93B vs. NAMS: $3.25B
IMVT [@Biotechnology] is valued at $7.93B. NAMS’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileNAMS’s FA Score has 1 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • NAMS’s FA Score: 1 green, 4 red.
According to our system of comparison, NAMS is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 2 TA indicator(s) are bullish while NAMS’s TA Score has 3 bullish TA indicator(s).

  • IMVT’s TA Score: 2 bullish, 5 bearish.
  • NAMS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both IMVT and NAMS are a bad buy in the short-term.

Price Growth

IMVT (@Biotechnology) experienced а -2.00% price change this week, while NAMS (@Biotechnology) price change was -6.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

IMVT is expected to report earnings on Aug 06, 2026.

NAMS is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($7.93B) has a higher market cap than NAMS($3.25B). IMVT YTD gains are higher at: 51.928 vs. NAMS (-20.781). NAMS has higher annual earnings (EBITDA): -214.95M vs. IMVT (-532.49M). IMVT has more cash in the bank: 902M vs. NAMS (636M). NAMS has less debt than IMVT: NAMS (23K) vs IMVT (72K). NAMS has higher revenues than IMVT: NAMS (22.6M) vs IMVT (0).
IMVTNAMSIMVT / NAMS
Capitalization7.93B3.25B244%
EBITDA-532.49M-214.95M248%
Gain YTD51.928-20.781-250%
P/E RatioN/AN/A-
Revenue022.6M-
Total Cash902M636M142%
Total Debt72K23K313%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
52
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMVTNAMS
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
54%
MACD
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signal:
Gain/Loss:
NAMS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DGLO23.980.18
+0.76%
First Trust RBA Deglobalization ETF
AOR68.530.04
+0.06%
iShares Core 60/40 Balanced Allc ETF
TEMX33.36N/A
N/A
Touchstone Sands Cap EM ex-China Gr ETF
HUSV41.00-0.08
-0.19%
First Trust Hrzn MgdVolatil Domestic ETF
GQRE65.49-0.59
-0.89%
FlexShares Glbl Quality Real Estate ETF

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-2.18%
ROIV - IMVT
65%
Loosely correlated
-1.77%
KURA - IMVT
53%
Loosely correlated
-3.22%
SYRE - IMVT
46%
Loosely correlated
-3.12%
NRIX - IMVT
46%
Loosely correlated
-1.57%
DYN - IMVT
42%
Loosely correlated
-2.14%
More

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with PTGX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
-2.35%
PTGX - NAMS
42%
Loosely correlated
-1.44%
IMVT - NAMS
40%
Loosely correlated
-2.18%
ROIV - NAMS
39%
Loosely correlated
-1.77%
VKTX - NAMS
37%
Loosely correlated
-4.14%
PCVX - NAMS
37%
Loosely correlated
-3.36%
More